Heparin Sodium and 0.9% Sodium Chloride Injection: leak in intravenous bag
Last updated
Summary
Product
Heparin Sodium and 0.9% Sodium Chloride Injection
Issue
Health products - Product quality
What to do
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Heparin Sodium and 0.9% Sodium Chloride Injection (1000 Units/ 500 mL) |
Heparin Sodium and 0.9% Sodium Chloride Injection (1000 Units/ 500 mL) |
DIN 00828750 |
solution |
Heparin (Heparin Sodium) 2 unit/ml, Sodium Chloride 9mg/ml |
W1F29B1, W1F10B1, W1G28B1, W1I22B1, W1K04B1, W1K11B1 |
Issue
| Intravenous bag may be leaking in affected lot |
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers, Healthcare Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
|
Baxter Corporation. 7125 Mississauga Rd, Mississauga, Ontario L5N 0C2 |
Published by
Health Canada
Audience
General public
Health professionals
Hospitals
Recall class
Type I
Identification number
RA-63896
Get notified
Receive notifications for new and updated recalls and alerts by category.